Literature DB >> 6472532

Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.

C A Johnson, P G Welling, S W Zimmerman.   

Abstract

Parenteral cephalosporins are widely used to treat peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). Few data exist on oral antibiotics in treating this disease. This study examined the pharmacokinetics of oral cephradine in noninfected patients on CAPD. Assays for cephradine in dialysate and urine were performed by high-performance liquid chromatography. Following a 500-mg dose, the peak dialysate cephradine concentration was 8.7 +/- 1.4 micrograms/ml. The peak urinary concentration was 201 +/- 119 micrograms/ml. The maximum peritoneal clearance was 4.3 +/- 0.3 ml/min/1.73 m2. Dialysate cephradine concentrations were inadequate against Staphylococcus epidermidis and most gram-negative bacteria found in CAPD-associated peritonitis, but may be adequate for most strains of other gram-positive organisms causing this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472532     DOI: 10.1159/000183279

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

Review 1.  Drug therapy in continuous ambulatory peritoneal dialysis patients.

Authors:  R Janknegt; J H Koelman
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

2.  Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.

Authors:  M Martea; Y A Hekster; T B Vree; A J Voets; J H Berden
Journal:  Pharm Weekbl Sci       Date:  1987-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.